- 1. 131-I-Anti-B1 Monoclonal Antibody
- [A monoclonal antibody directed against a protein (CD20) expressed on the surface of B-lymphocytes and radiolabeled with the radioisotope I 131 with potential antineoplastic activity. Iodine 131 tositumomab delivers radiation selectively to neoplastic CD20-expressing B-lymphocytes cells, thereby decreasing the risk of systemic radiotoxicity. ( NCI )] (UMLS (NCI) C0768182) I 131 Bexxar;
I 131 Monoclonal Antibody Anti-B1;
I 131 Tositumomab;
I131-MOAB-B1;
Iodine I 131 MOAB Anti-B1;
Iodine I 131 Monoclonal Antibody Anti-B1;
Iodine I 131 Tositumomab;
Iodine-131 Anti-B1 Antibody;
Iodine-131 Anti-CD20 Monoclonal Antibody;
Iodine-131 Tositumomab;
TOSITUMOMAB IODINE-131;
TOSITUMOMAB IODINE-131 PREPARATION =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor =anti-B1;
Unclassified Ingredients =TOSITUMOMAB IODINE-131 0.61 MCI/ML;
TOSITUMOMAB IODINE-131 VIAL 5.6MCI/ML | - 2. I 131 Antiferritin Immunoglobulin
- [A radioimmunoconjugate of a rabbit antihuman ferritin IgG labeled with iodine 131 (I-131). Using anti-ferritin IgG as a carrier for I-131 may result in the targeted imaging and/or destruction of cells expressing ferritin. Observed in 35% to 100% of patients with hepatocellular carcinoma, high serum ferritin levels may be due to ferritin production by the tumor cells, or related to the associated iron overload and/or cirrhosis. ( NCI )] (UMLS (NCI) C0280029) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
home
